Overview

Magnetic Seizure Therapy for Psychotic Disorders

Status:
NOT_YET_RECRUITING
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
This trial aims to evaluate the efficacy and safety of Magnetic Seizure Therapy (MST) as an augmentation of antipsychotic medications for psychosis.
Phase:
NA
Details
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Treatments:
Amisulpride
Antipsychotic Agents
Aripiprazole
Quetiapine Fumarate
Risperidone